AGN
$ABBV AbbVie Has It All: Growth, Dividend Growth and Compelling Valuation (NYS:ABBV)
2019-06-25
Introduction I have held AbbVie (ABBV) since it was originally spun off from Abbott Labs. Moreover, I have been aggressively adding to my position for clients needing current income and dividend growth. All in all, it has been an excellent performer in spite of the fact that it is being ridiculously undervalued by Mr. Market. […]
7 Intriguing Healthcare Growth Stocks in the S&P 500: Part 2
2016-08-11
Introduction The S&P 500 index is commonly used as a benchmark that investors use to measure the performance of their individual portfolios against. However, the S&P 500 is comprised of a very diverse group of companies. Just about every classification of company you can imagine can be found in the S&P 500. Furthermore, it is […]